UBS Group AG - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 43 filers reported holding VIRACTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$68
-98.6%
65
-98.0%
0.00%
Q4 2022$4,757
-56.8%
3,258
+31.8%
0.00%
Q3 2022$11,0002,472
+27366.7%
0.00%
Q2 2022$090.0%0.00%
Q1 2022$090.0%0.00%
Q4 2021$0
-100.0%
9
-99.0%
0.00%
Q3 2021$7,000871
+9577.8%
0.00%
Q2 2021$09
-18.2%
0.00%
Q1 2021$0110.00%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 288,571$1,120,0000.80%
Samsara BioCapital, LLC 689,709$2,676,0000.71%
BVF INC/IL 3,614,662$14,025,0000.68%
HAMILTON LANE ADVISORS LLC 71,491$277,0000.11%
MAI Capital Management 647,950$2,514,0000.05%
Laurion Capital Management LP 698,000$2,708,0000.04%
Jasper Ridge Partners, L.P. 92,939$361,0000.02%
BOURGEON CAPITAL MANAGEMENT LLC 20,500$80,0000.02%
Ergoteles LLC 155,562$604,0000.02%
Clear Harbor Asset Management, LLC 25,000$97,0000.01%
View complete list of VIRACTA THERAPEUTICS INC shareholders